• Bestatin (Ubenimex): Translational Leverage in Protease-Driv

  2026-07-14

  This thought-leadership article offers translational researchers an advanced synthesis of mechanistic insight, protocol guidance, and strategic context for deploying Bestatin (Ubenimex) in protease-related oncology. Bridging foundational enzymology with leading-edge translational applications, it critically evaluates recent evidence, including paradoxical pro-angiogenic effects, and provides clear guidance on integrating Bestatin into multidrug resistance and apoptosis assays. The discussion elevates beyond conventional product summaries to address both emerging challenges and new opportunities for competitive innovation.

• Demethyleneberberine: Optimizing Workflows in NSCLC and Infl

  2026-07-14

  Demethyleneberberine (DMB) stands out as a multi-pathway modulator, enabling advanced modeling of inflammation, cancer, and neurodegeneration. This article translates recent mechanistic discoveries into actionable protocols, troubleshooting insights, and comparative use-cases that unlock the full research potential of DMB from APExBIO.

• Anagliptin (SK-0403): DPP-4 Inhibition and Vascular Mechanis

  2026-07-13

  Anagliptin (SK-0403) stands out as both a potent DPP-4 inhibitor and a direct modulator of vascular tone, uniquely activating Kv channels and SERCA pumps. This dual action empowers researchers with deeper insights into diabetes and cardiovascular physiology, expanding experimental possibilities beyond glycemic control.

• DPPH Radical Assay: Advanced Antioxidant Screening Workflows

  2026-07-13

  Leverage DPPH (2,2-Diphenyl-1-Picrylhydrazyl) Radical for fast, reproducible in vitro antioxidant screening—even in complex natural extracts. Discover practical assay enhancements, troubleshooting tips, and real-world insights from the latest comparative research.

• Multianimal MRI Accelerates Tumor Monitoring in Pancreatic M

  2026-07-12

  Kempinska et al. present a multianimal MRI protocol that enables efficient, high-resolution detection and longitudinal measurement of pancreatic tumors in KPC mouse models. This method reduces imaging time and cost while maintaining sensitivity, streamlining preclinical evaluation of therapeutics such as gemcitabine.

• DPPH Radical Assays: Advanced Insights for Antioxidant Disco

  2026-07-10

  Explore the scientific nuances of DPPH (2,2-Diphenyl-1-Picrylhydrazyl) radical assays for in vitro antioxidant screening. This article delivers advanced analysis on assay design, solubility, and the latest comparative research to guide precise, high-throughput antioxidant evaluation.

• BMAL1 Phase Separation Orchestrates Circadian Transcriptiona

  2026-07-09

  Gao et al. demonstrate that BMAL1, a core circadian clock protein, regulates circadian rhythms by forming dynamic phase-separated nuclear condensates, dependent on its intrinsically disordered region and phosphorylation state. This mechanistic insight clarifies the temporal gap between BMAL1-DNA binding and downstream transcription, and highlights new avenues for investigating protein phosphorylation in chronobiology.

• Trelagliptin Succinate: Applied Workflows in Diabetes Resear

  2026-07-09

  Trelagliptin succinate (SYR-472 succinate) empowers translational diabetes and metabolic research with its potent, selective DPP-4 inhibition and proven once-weekly activity. Discover actionable protocols, troubleshooting tactics, and innovative cross-disciplinary applications that set it apart from other DPP-4 inhibitors.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn

  2026-07-08

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) addresses the challenge of protein degradation during extraction, especially in workflows where EDTA is incompatible. It is suitable for Western blotting, co-IP, kinase assays, and other protease-sensitive protocols. Avoid use where DMSO disrupts cell or protein integrity or where protease inhibition is unnecessary.

• ARCA Cy3 EGFP mRNA (5-moUTP): Deep Dive Into Mechanisms & As

  2026-07-08

  Explore the scientific mechanisms and translational assay design considerations underlying ARCA Cy3 EGFP mRNA (5-moUTP), a 5-methoxyuridine modified mRNA. Gain unique insights beyond workflow guides, focusing on molecular engineering, immune suppression, and emerging delivery innovations.

• CUDC-907: Technical Guidance for Dual PI3K and HDAC Inhibiti

  2026-07-07

  CUDC-907 is a dual PI3K and HDAC inhibitor designed for precise modulation of PI3K/AKT and histone acetylation pathways in established cancer cell models. It is optimized for in vitro workflows requiring controlled cell cycle arrest and apoptosis assessment, but should not be used for diagnostic or therapeutic purposes.

• A20 Modulates Oxidized Self-DNA-Driven Inflammation in AKI

  2026-07-07

  This study elucidates how the ubiquitin-editing enzyme A20 mitigates oxidized self-DNA-induced inflammation in acute kidney injury (AKI) by interfering with the NLRP3 inflammasome pathway. The findings reveal a distinct mechanism for controlling sterile inflammation in AKI, opening new translational avenues for inflammasome-targeted therapies.

• Demethyleneberberine (N2087): Reliable Cell Assays & Pathway

  2026-07-06

  This article offers a scenario-driven, evidence-based guide for biomedical researchers and technicians considering Demethyleneberberine (SKU N2087) in cell viability, proliferation, and cytotoxicity assays. It addresses experimental pitfalls, data reproducibility, and protocol optimization, drawing on robust literature and performance data to position Demethyleneberberine as a trusted solution for pathway-targeted workflows.

• Tacrine Hydrochloride Hydrate: Scaffold for Next-Gen Alzheim

  2026-07-06

  Explore the advanced use of Tacrine hydrochloride hydrate in Alzheimer’s disease research. This article uncovers its role as a molecular scaffold for multi-target drug development and offers unique assay insights for neurodegenerative disease models.

• Phosphatase Inhibitor Cocktail 2: Safeguarding Proteostasis

  2026-07-05

  Explore how Phosphatase Inhibitor Cocktail 2 enables precise protein phosphorylation preservation in aging and neurodegeneration studies. This article uniquely unpacks SIRT6-driven proteostasis loss, offering actionable insight for signaling research.

16062 records 1/1071 page Next 12345 下5页 Last page